We are delighted to invite you to participate in the 3rd International Human Gene Therapy Conference 2026, a premier Gene Therapy Conference Boston and globally recognized International Gene Therapy Conference USA, taking place from March 23–25, 2026, in the dynamic and historic city of Boston, USA. This prestigious Cell and Gene Therapy Conference serves as a leading platform for sharing groundbreaking developments in human gene therapy, genome editing technologies, and cell-based therapeutic innovations.

Recognized as a key Gene Therapy Forum 2026 and Biotechnology Conference Boston 2026, the event will highlight advances in gene therapy research, cell and gene therapy innovation, and emerging next-generation therapeutics that are reshaping modern healthcare. The conference will also explore cutting-edge topics including CRISPR gene therapy, viral vector manufacturing, AAV gene therapy development, and advancements in advanced biologics and regenerative medicine.

As the field of gene therapy continues to accelerate at an unprecedented pace, this Gene Therapy Summit Boston 2026 brings together the brightest minds in biomedical science, clinical research, biotechnology, pharmaceutical development, and regulatory affairs. Attendees will include world-renowned scientists, clinicians, biotech entrepreneurs, policymakers, and industry stakeholders, creating a truly international gene and cell therapy event in Boston focused on collaboration and innovation

Explore the Future of Gene and Cell Therapies

Gene therapy holds the promise of treating—and potentially curing—a wide range of genetic and acquired conditions once considered incurable. From monogenic disorders such as sickle cell disease and hemophilia to complex diseases including cancers and neurodegenerative disorders, clinical gene therapy advancements are rapidly transforming patient care.

This Advanced Therapies Conference USA will showcase progress in precision medicine, translational medicine, and regenerative approaches that bridge scientific discovery with real-world clinical applications. Through expert-led discussions, scientific presentations, and collaborative networking opportunities, participants will gain insights into the evolving landscape of genome editing, innovative therapeutic platforms, and the future of personalized healthcare.

Join global leaders at this premier Genome Editing Conference 2026 and experience how innovation in cell and gene therapy is shaping the next era of medicine.

We are pleased to invite you to attend the 3rd International Human Gene Therapy Conference 2026, which will take place from March 23–25, 2026, in Boston, USA. This distinguished global event is designed to bring together a diverse and interdisciplinary group of experts, including pioneering scientists, clinical researchers, biotech professionals, early-career investigators, and students from around the world.

The conference serves as a vibrant platform to foster collaboration, exchange knowledge, and showcase the most recent advances in gene therapy, genome editing, and cell-based therapeutics. It aims to highlight the transformative potential of gene therapy in treating genetic and acquired diseases and to explore the clinical, scientific, regulatory, and commercial developments driving the field forward.

Attendees will benefit from an engaging program that includes keynote lectures by internationally recognized leaders, thematic technical sessions, poster presentations, and ample opportunities for professional networking. Topics will span a wide range of areas, including CRISPR and gene editing technologies, viral and non-viral vectors, therapeutic gene delivery, clinical trial outcomes, and ethical and regulatory perspectives.